Literature DB >> 27479194

Comparative study on the antioxidant capacities of synthetic influenza inhibitors and ellagic acid in model systems.

Elitsa L Pavlova1, Nikolay N Zografov2, Lora S Simeonova3.   

Abstract

This study compares the antioxidant capacities in vitro of several synthetic and natural compounds applied and researched for influenza treatment - oseltamivir, isoprinosine, ellagic acid, vitamin E and vitamin C. Three chemical systems are utilized for the generation of reactive oxygen species (ROS) at pH 7.4 and pH 8.5: (1) Fenton's (Fe2++H2O2) for OH and -OH species (2) H2O2 (3) NADH-phenazinemethosulfat, for superoxide radicals (O2-). The kinetics was evaluated by lucigenin-enhanced chemiluminescence. The calculated constants of inhibition k7 describe the antioxidant capacity at the moment of oxidative burst. Their values do not necessarily correspond to the calculated total antioxidant activity. The obtained results revealed that the synthetic anti-influenza drugs (oseltamivir and isoprinosine) as well as ellagic acid possess pronounced scavenging properties mostly against superoxide radicals, comparable and higher than that of traditional natural antioxidants. Quantitative analysis of the antioxidant effects of the examined synthetic substances was performed. The results compared the corresponding effect of the average physiological concentrations and the applied therapeutic antioxidant dose. With these experiments we registered new aspects of their therapeutic activities, due to antioxidant properties against hydroxyl, superoxide radicals and H2O2 oxidation.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Constant of inhibition; Ellagic acid; Ellagic acid (PubChem CID 5281855); Isoprinosine; Isoprinosine (PubChem CID 37510); Luminescence; Oseltamivir; Oseltamivir (PubChem CID 65028); Vitamin C; Vitamin C (PubChem CID 54670067); Vitamin E; Vitamin E (PubChem CID 20353)

Mesh:

Substances:

Year:  2016        PMID: 27479194     DOI: 10.1016/j.biopha.2016.07.046

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

Review 1.  Ellagic acid in suppressing in vivo and in vitro oxidative stresses.

Authors:  Alam Zeb
Journal:  Mol Cell Biochem       Date:  2018-01-31       Impact factor: 3.396

2.  Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters.

Authors:  Ying-Si Wu; Jar-Yi Ho; Cheng-Ping Yu; Chun-Jung Cho; Chia-Lun Wu; Cheng-Shuo Huang; Hong-Wei Gao; Dah-Shyong Yu
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 3.  Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Carla Marina Salgado Castillo; Rodrigo Caroca; Marco A Lazo-Vélez; Halyna Antonyak; Alexandr Polishchuk; Roman Lysiuk; Petro Oliinyk; Luigi De Masi; Paola Bontempo; Miquel Martorell; Sevgi Durna Daştan; Daniela Rigano; Michael Wink; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2022-02-21       Impact factor: 6.543

4.  Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses.

Authors:  Khaled AbouAitah; Abdou K Allayh; Jacek Wojnarowicz; Yasser M Shaker; Anna Swiderska-Sroda; Witold Lojkowski
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.